This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Hunting for Bargains

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- What's the secret to successful bargain hunting? Jim Cramer told his Mad Money viewers Wednesday that all they need to do is look at last quarter's winners.

Cramer said Williams Companies (WMB) was the top performer last quarter, and this oil and natural gas pipeline powerhouse is still a buy. Cramer was also bullish on the number two performer, Newfield Exploration (NFX), which is growing production at 28% a year.

Other standouts from last quarter include Micron Technology (MU) and Sandisk (SNDK). Cramer said both these stocks are buys on weakness. He was also bullish on Anadarko Petroleum (APC), a stock he owns for his charitable trust, Action Alerts PLUS.

Cramer told viewers to sell Iron Mountain (IRM) because that story has played out, but he still likes Vertex Pharmaceuticals (VTRX) and Molson Coors (TAP) as beer sales continue to rebound.

Reinventing Alcoa

Companies really can reinvent themselves, Cramer told viewers, sometimes even without a push from activist investors. That has certainly been the case with Alcoa (AA - Get Report), a stock that popped 5.7% today on another strong quarter, offering investors a 40% gain for the year.

Cramer said Alcoa continues to reinvent itself: First by lowering costs, thanks to closing high cost plants and boosting earnings per share, but also by innovating, creating new metals and new uses for aluminum in everything from cars and aircraft to contraction and consumer products.

Alcoa's transformation is only just beginning, Cramer concluded, which is why he continues to be a fan of the company and its CEO.

Off the Charts

In the "Off The Charts" segment, Cramer went head to head with colleague Bob Lang over the direction of the biotechs, namely Biogen Idec (BIIB - Get Report), Regeneron (REGN - Get Report), Celgene (CELG - Get Report) and Gilead Sciences (GILD - Get Report).

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AA $11.10 0.00%
AGN $307.51 0.00%
BIIB $404.28 0.00%
CELG $119.52 0.00%
GILD $115.04 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs